Tumor growth, invasion, and angiogenesis in malignant gliomas

Journal of Neuro-Oncology

Volumn 77, Issue 3, 2006, Pages 295-296

  Wong, Eric T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Malignant gliomas

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GADOLINIUM; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER INVASION; CANCER RELAPSE; CONTRAST ENHANCEMENT; GLIOBLASTOMA; HIPPOCAMPUS; HUMAN; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PONS; PYRAMIDAL TRACT; SIGNAL TRANSDUCTION; SKULL IRRADIATION; SURGICAL TECHNIQUE; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; BRAIN TUMOR; CASE REPORT; GLIOMA; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TEMPORAL LOBE; VASCULARIZATION;

BRAIN NEOPLASMS; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; TEMPORAL LOBE;

EID: 33748434963     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9042-8     Document Type: Article

References (6)

1. Louis DN, Holland EC, Cairncross JG, 2001 Glioma classification, a molecular reappraisal Am J Pathol 159: 779-786
2. Phuphanich S, Brat DJ, Olson JJ, 2004 Delivery systems and molecular targets of mechanism-based therapies for GBM Expert Rev Neurother 4: 649-663
3. Groves MD, Puduvalli VK, Hess KR, et al, 2002 Phase II trial of temozolomide plus the matrix metalloprotease inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme J Clin Oncol 20: 1383-1388
4. Levin V, Phuphanich S, Glantz MJ, et al, 2002 Randomized phase II study of temozolomide (TMZ) with and without the matrix metalloprotease (MMP) inhibitor prinomastat in patients (pts) with glioblastoma multiforme (GBM) following best surgery and radiation therapy Proceed ASCO 21: 26a
5. Fine HA, Figg WD, Jaeckle K, et al, 2000 Phase II trial of the antiangiogenic agent thalidomide in patients with recurrence high-grade gliomas J Clin Oncol 18: 708-715
6. Marx GM, Pavlakis N, McCowatt S, et al, 2001 Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme J Neurooncol 54: 31-38